text

Reach more than 230,000 doctors through our digital channel and help them stay up-to-date with new therapies and new developments in your therapeutic areas.

Book a demo

text

Reach more than 230,000 doctors through our digital channel and help them stay up-to-date with new therapies and new developments in your therapeutic areas.

Asset 66

Book a demo

160K

ACTIVE DOCTORS IN THE LAST 30 DAYS

230K

REGISTERED DOCTORS

4,9M

USES PER MONTH

Asset 16-1

GO DIGITAL

Doctors are already getting 30% of their medical information from digital channels and this trend is only accelerating.

Asset 17

REACH DOCTORS IN 12 COUNTRIES

We are present in 12 countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, Italy, Germany, Spain, Poland and France.

Asset 14

TARGET YOUR ADS

Directly target doctors of relevant specialties and improve the results of your product advertisements.

Book a demo

Empower doctors with Mediately PRO

Get a single or multi-user access and make medical knowledge accessible with PRO features:

Interactions checker

Drug Interaction Checker & Resolver

Identify interactions in a clear overview & review clinical implications and drug alternatives


no connection

Offline Access

Provides offline access to users' favorite features, so they can use the app even without Wi-Fi or mobile data


Restrictions icon-2

Restrictions of use

Gain insights into renal, hepatic, pregnancy, and breastfeeding restrictions at a glance


Get Mediately PRO for businesses

Digital Doctor Survey

Digital Doctor is a survey conducted by Mediately among its doctor users and is one of the largest surveys of its kind in Europe.

It gathers information from European doctors and provides important insights into their needs and views. It reflects doctors' views on medical trends, work satisfaction and relations with pharma representatives.

Learn about doctors' behaviour

Digital Doctor Survey

Digital Doctor is a survey conducted by Mediately among its doctor users and is one of the largest surveys of its kind in Europe.

It gathers information from European doctors and provides important insights into their needs and views. It reflects doctors' views on medical trends, work satisfaction and relations with pharma representatives.

Asset 30@2x

Learn about doctors' behaviour

Mediately Insights

The Mediately Insights platform was designed to demonstrate how successful your campaigns with the Mediately app are at any time. Moreover, it also provides you with insights about your target audiences, including the most frequently searched drugs in your country, top searches by speciality, number of active Mediately App users and app usage frequency.

You can sign up for free and start exploring these insights for your preferred speciality and country today!

Sign up to Mediately Insights

Mediately Insights

Mediately Insights is a platform we created to provide valuable information about your target specialty and show the success of your campaigns with the Mediately app. It tracks your advertisements and enables you to export reports in multiple formats for any time range.

Insights-image@2x

Take a peek and see how our platform can help you plan and analyze your campaigns. It’s free and you can cancel your registration anytime if it doesn’t meet your needs.

Sign up to Mediately Insights

Visit our blog

SmPC-updates

Nowadays, being well-informed about changes in the industry is a basic prerequisite for anyone who...

5 minute read

Read more  


buyers-journey

Having a solid healthcare marketing strategy is paramount to the success of any pharmaceutical...

6 minute read

Read more  


healthcare-trends

Doctors are being flooded with an excessive amount of information and burdened with an excessive...

3 minute read

Read more  

Our partners

partners mobile

 

Our partners

Our partners
Asset 18

Subscribe to email updates

We’ll be sending you information and news about doctors' behaviour, digital advertising and solutions which we believe may be useful to you.

Join the newsletter

You can always unsubscribe from our newsletter.